International Journal of Colorectal Disease

, Volume 34, Issue 11, pp 1915–1924 | Cite as

Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study

  • Shaobo Mo
  • Zheng Zhou
  • Zhen Ying
  • Weixing Dai
  • Wenqiang Xiang
  • Lingyu Han
  • Qingguo Li
  • Renjie WangEmail author
  • Guoxiang CaiEmail author
Original Article



The aim of this study is to evaluate the epidemiology of and prognostic factors for appendiceal carcinomas (ACs).


All cases of ACs registered in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2014 were retrospectively identified in this study. Age-adjusted incidence and survival rates were calculated.


We analyzed 7170 patients with ACs. We observed a significant increase in the reported annual age-adjusted incidence of ACs from 1973 (0.18/100,000) to 2014 (1.11/100,000). The elevation of the incidence was noted in all the histological types, stages, and grades. The most common histological type varied by race, with the appendiceal mucinous adenocarcinoma (AMA) being the most common in white, Asian/Pacific Islander, and American Indian/Alaskan Native patients, and the appendiceal adenocarcinoma (AA) being the most common in African American patients. In multivariate analysis of patients with all ACs, gender (P < 0.001), year of diagnosis (P < 0.001), age (P < 0.001), race (P < 0.001), tumor grade (P < 0.001), disease stage (P < 0.001), retrieved regional lymph nodes (P < 0.001), type of surgery performed (P = 0.002), and histologic subtype (P < 0.001) were predictors of outcome. Survival time for all ACs increased from the 1973–1993 period to the 1994–2014 period (HR 0.76; 95% CI, 0.69 to 0.85). Additionally, the 5-year survival rates were 88% for malignant carcinoid, 70% for goblet cell carcinoid, 51% for colonic type adenocarcinoma, 59% for mucinous adenocarcinoma, and 25% for signet ring cell type.


We observed increased reported incidence of ACs and increased survival durations over time, suggesting that clinicians pay more attention to ACs and mastering the characteristic of these tumors.


Appendiceal carcinoma Epidemiology Incidence Survival outcomes Prognostic factors 



The authors would like to thank the Surveillance, Epidemiology, and End Results (SEER) database for the support.

Funding information

This study was supported by the National Key R&D Program of China (No. 2016YFC0905300 and 2016YFC0905301), the Grant of Science and Technology Commission of Shanghai Municipality (No. 16401970502), the Grant of National Natural Science Foundation of China (No. 81572351), the Shanghai Shenkang Program (No. SHDC12014206), the National Science Foundation of China (No. 81702353), and Shanghai Municipal Natural Science Foundation (17ZR1406400).

Compliance with ethical standards

Ethics approval and consent to participate

The Ethical Committee and Institutional Review Board of the Fudan University Shanghai Cancer Center reviewed and approved this study protocol.

Competing interests

The authors declare that they have no competing interests.


The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Supplementary material

384_2019_3387_MOESM1_ESM.docx (14 kb)
ESM 1 (DOCX 14 kb)
384_2019_3387_MOESM2_ESM.docx (23 kb)
ESM 2 (DOCX 22 kb)


  1. 1.
    Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. 68(1):7–30Google Scholar
  2. 2.
    Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E (2016) Prognostic factors for survival in advanced appendiceal cancers. Cancer Biomark 17(4):457–462CrossRefGoogle Scholar
  3. 3.
    Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34(2):196–201CrossRefGoogle Scholar
  4. 4.
    Deans GT, Spence RA (1995) Neoplastic lesions of the appendix. Br J Surg 82(3):299–306CrossRefGoogle Scholar
  5. 5.
    McCusker ME, Cote TR, Clegg LX, Sobin LH (2002) Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer. 94(12):3307–3312CrossRefGoogle Scholar
  6. 6.
    Noone AM, Lund JL, Mariotto A, Cronin K, McNeel T, Deapen D, Warren JL (2016) Comparison of SEER treatment data with Medicare claims. Med Care 54(9):e55–e64CrossRefGoogle Scholar
  7. 7.
    Marmor S, Portschy PR, Tuttle TM, Virnig BA (2015) The rise in appendiceal cancer incidence: 2000-2009. J Gastrointest Surg 19(4):743–750CrossRefGoogle Scholar
  8. 8.
    Buuren SV, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45:1–67CrossRefGoogle Scholar
  9. 9.
    Marshall A, Altman DG, Holder RL, Royston P (2009) Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol 9:57CrossRefGoogle Scholar
  10. 10.
    Kocher KE, Meurer WJ, Fazel R, Scott PA, Krumholz HM, Nallamothu BK (2011) National trends in use of computed tomography in the emergency department. Ann Emerg Med 58(5):452–62 e3CrossRefGoogle Scholar
  11. 11.
    Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL (2007) Trends in colonoscopy for colorectal cancer screening. Med Care 45(2):160–167CrossRefGoogle Scholar
  12. 12.
    Benedix F, Reimer A, Gastinger I, Mroczkowski P, Lippert H, Kube R, Study Group Colon/Rectum Carcinoma Primary T (2010) Primary appendiceal carcinoma--epidemiology, surgery and survival: results of a German multi-center study. Eur J Surg Oncol 36(8):763–771CrossRefGoogle Scholar
  13. 13.
    Piso P, Bektas H, Werner U, Schlitt HJ, Kubicka S, Bornscheuer A, Manns M, Klempnauer J (2001) Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 27(3):286–290CrossRefGoogle Scholar
  14. 14.
    El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A (2012) The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol 19(1):110–114CrossRefGoogle Scholar
  15. 15.
    Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, Oliff L, Schlag P (1990) Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 50(18):5790–5794PubMedGoogle Scholar
  16. 16.
    Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gomez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, Gonzalez-Moreno S, Van Der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Colorectal SurgeryFudan University Shanghai Cancer CenterShanghaiChina
  2. 2.Department of Oncology, Shanghai Medical CollegeFudan UniversityShanghaiChina

Personalised recommendations